Those would be good metrics to go by if we had more consistent figures to work with, also a lot of other companies don't just provide FR as their main sales product, so comparing them would be difficult.
IMO we needed probably close to two years (September last year to the start of July next year) from when we first started receiving revenue to start getting into a routine where we can more accurately cost things.
Until then revenue streams and the cost of product from suppliers to us, and the costs of trials etcetera, allows COGS and other metrics to be unrealistic, until then there are to many variables to be anywhere near accurate.
Cheers.
AJX Price at posting:
63.0¢ Sentiment: Buy Disclosure: Held
